View - ResearchGate
View - ResearchGate View - ResearchGate
Phage Display of Peptides in Ligand Selection 119 3.6. Characterization of a Phage Peptide as a Mimotope It is important to characterize the selected phage clones for their ability to mimic the native antigen. Ideally, two ELISAs should be performed involving competition of the phage with the native antigen for binding to the parent antibody and checking the phage does not bind to the constant or framework regions of the antibody using a relevant isotype control antibody. Examples of the typical results are shown in Fig. 2B and C. The same ELISA described in Subheading 3.2 should be used with the following modifications. 3.6.1. Antigen Competition ELISA Step 3: Various concentrations of antigen competitor (usually 0.1–200 μg/ml) can be mixed with a constant phage dilution (50 μl of each). The optimal phage concentration to be used can be determined first by titrating the phage and taking a dilution at the top of the binding curve where it begins to plateau. 3.6.2. Isotype Control ELISA Step 1: Wells should be coated with the isotype control antibody and binding compared to the original antibody. 3.7. Characterization of the Synthetic Peptide Once it has been established the selected phage clone(s) are true mimotopes, it is important to prove the peptides are functional in the absence of the phage framework (data not shown). This can be performed using the ELISA described in Subheading 3.2 with the following modifications. Step 3: Various concentrations of peptide (usually 1–500 μg/ml) can be mixed with a constant phage dilution. The optimal phage concentration to be used can be determined by titrating the phage and taking a dilution at the top of the binding curve where it begins to plateau. 3.8. Preparation of the Peptide Affinity Resin (see Note 2) 1) For a 2-ml column weigh out 2 mg of peptide. If the peptide requires organic solvent (e.g., dimethyl sulfoxide or dimethyl formamide) keep the volume of solvent to a minimum, approximately 100–200 μl and mix until the peptide is fully dissolved, then make up to 1 ml with coupling buffer. If the peptide is soluble dissolve directly into 1 ml of coupling buffer. 2) Mix the NHS-activated Sepharose until an even gel suspension is apparent. Measure 2 ml of the resin and wash with 15 column volumes (CV) of cold 1 mM HCl.
- Page 194: II Affinity Chromatography Using Pu
- Page 198: 94 Roque and Lowe market, with 14 F
- Page 202: 96 Roque and Lowe and RasMol V2.7.1
- Page 206: 98 Roque and Lowe house using, for
- Page 210: 100 Roque and Lowe Gly71 and Gly72)
- Page 214: 102 Roque and Lowe dissolved in ace
- Page 218: 104 Roque and Lowe equilibration bu
- Page 222: 106 Roque and Lowe of color. Purple
- Page 226: 108 Roque and Lowe 5. Fassina, G.,
- Page 230: 8 Phage Display of Peptides in Liga
- Page 234: Phage Display of Peptides in Ligand
- Page 238: Phage Display of Peptides in Ligand
- Page 242: Phage Display of Peptides in Ligand
- Page 248: 120 Casey et al. 3) Mix the washed
- Page 252: 122 Casey et al. C Absorbance 450nm
- Page 256: 124 Casey et al. References 1. Smit
- Page 260: 126 Forde Utilization of the GST-gl
- Page 264: 128 Forde 3. Methods 3.1. Productio
- Page 268: 130 Forde 4. Wash the column with 5
- Page 272: 132 Forde 5. BDGE is toxic (by inha
- Page 276: 134 Forde 250 Elution in response u
- Page 280: 136 Forde References 1. Wils P, Esc
- Page 284: 138 Charlton and Zachariou 1. Intro
- Page 288: 140 Charlton and Zachariou and non-
- Page 292: 142 Charlton and Zachariou the maxi
Phage Display of Peptides in Ligand Selection 119<br />
3.6. Characterization of a Phage Peptide as a Mimotope<br />
It is important to characterize the selected phage clones for their ability to<br />
mimic the native antigen. Ideally, two ELISAs should be performed involving<br />
competition of the phage with the native antigen for binding to the parent<br />
antibody and checking the phage does not bind to the constant or framework<br />
regions of the antibody using a relevant isotype control antibody. Examples of<br />
the typical results are shown in Fig. 2B and C. The same ELISA described in<br />
Subheading 3.2 should be used with the following modifications.<br />
3.6.1. Antigen Competition ELISA<br />
Step 3: Various concentrations of antigen competitor (usually 0.1–200 μg/ml)<br />
can be mixed with a constant phage dilution (50 μl of each). The optimal phage<br />
concentration to be used can be determined first by titrating the phage and<br />
taking a dilution at the top of the binding curve where it begins to plateau.<br />
3.6.2. Isotype Control ELISA<br />
Step 1: Wells should be coated with the isotype control antibody and binding<br />
compared to the original antibody.<br />
3.7. Characterization of the Synthetic Peptide<br />
Once it has been established the selected phage clone(s) are true mimotopes,<br />
it is important to prove the peptides are functional in the absence of the phage<br />
framework (data not shown). This can be performed using the ELISA described<br />
in Subheading 3.2 with the following modifications.<br />
Step 3: Various concentrations of peptide (usually 1–500 μg/ml) can be<br />
mixed with a constant phage dilution. The optimal phage concentration to be<br />
used can be determined by titrating the phage and taking a dilution at the top<br />
of the binding curve where it begins to plateau.<br />
3.8. Preparation of the Peptide Affinity Resin (see Note 2)<br />
1) For a 2-ml column weigh out 2 mg of peptide. If the peptide requires organic<br />
solvent (e.g., dimethyl sulfoxide or dimethyl formamide) keep the volume of<br />
solvent to a minimum, approximately 100–200 μl and mix until the peptide is fully<br />
dissolved, then make up to 1 ml with coupling buffer. If the peptide is soluble<br />
dissolve directly into 1 ml of coupling buffer.<br />
2) Mix the NHS-activated Sepharose until an even gel suspension is apparent.<br />
Measure 2 ml of the resin and wash with 15 column volumes (CV) of cold<br />
1 mM HCl.